Intravitreal bevacizumab in the treatment of choroidal neovascularization from a traumatic choroidal rupture in a 9-year-old child.
To describe a case in which a 9-year-old boy who sustained a traumatic choroidal rupture, and later developed choroidal neovascularization (CNV), was successfully treated with intravitreal bevacizumab. Comprehensive ophthalmic evaluation, including fundus photography, fluorescein angiography, optical coherence tomography, and B-scan ultrasonography, was done to follow the patient's course and response to treatment over a 2-month period. Preinjection visual acuity was 20/200. Fluorescein angiography showed significant leakage, and optical coherence tomography revealed macular edema. One month after injection, visual acuity was 20/20, with resolution of leakage and edema by fluorescein angiography and optical coherence tomography, respectively. There was dramatic improvement in visual acuity from a single intravitreal injection of bevacizumab. This case shows promise for future applications of bevacizumab as treatment of CNV arising from a traumatic choroidal rupture.